Showing results (2401-2410 of 2,436) with videos related to

Sort By:
Pageof 244
BMJ Open|June 2, 2026
Treatable Traits for Asthma Management in Pregnancy (TTAP): protocol for an Australian multicentre prospective observational cohort studyJane E Grehan, Janet Bristow, Kelly Steel, et al.
JAMA|September 8, 2018
Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical TrialDorothy K Hatsukami, Xianghua Luo, Joni A Jensen, et al.
Pediatric Research|February 8, 2023
Tobacco smoke exposure, the lower airways microbiome and outcomes of ventilated childrenMatthew K Leroue, Kayla M Williamson, Paul C Curtin, et al.
Cancer Discovery|September 14, 2017
A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling RolesVito W Rebecca, Michael C Nicastri, Noel McLaughlin, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2008
5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Chinh V Tran, Lian-Sheng Li, et al.
JAMA Network Open|January 16, 2019
Association of a Care Coordination Model With Health Care Costs and Utilization: The Johns Hopkins Community Health Partnership (J-CHiP)Scott A Berkowitz, Shriram Parashuram, Kathy Rowan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2014
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinomaDarrell R Borger, Lipika Goyal, Thomas Yau, et al.
Molecular Cell|December 15, 2019
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in MelanomaMarie R Webster, Mitchell E Fane, Gretchen M Alicea, et al.
Journal of Virology|June 2, 2021
African-Lineage Zika Virus Replication Dynamics and Maternal-Fetal Interface Infection in Pregnant Rhesus MacaquesChelsea M Crooks, Andrea M Weiler, Sierra L Rybarczyk, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymeraseFrank Ruebsam, Douglas E Murphy, Chinh V Tran, et al.
Pageof 244